The angiotensin-converting enzyme (ACE) causes blood vessels to narrow, increasing blood pressure. Patients with AD show higher levels of ACE in their brains. The Alzheimerās Genome Project identified rare variants of the angiotensin-converting enzyme (ACE) that were associated with AD. One of these mutations increased the levels of the ACE1 ...
October 7, 2022
Getting to a Cure Why do we need a National Strategy? Ā The cost of care for Alzheimerās patients will overwhelm Medicare and Medicaid if not checked within the next few years. With funding from private and public sources heavily constrained, it is essential to make each research dollar count. There is enough ...
March 26, 2009
January 30, 2024
We’re planning some changes to our website to keep you updated on our progress toward a cure and give you the tools you need to engage your friends and family in this critical work to end Alzheimer’s disease. You have helped build Cure Alzheimer’s Fund and have supported groundbreaking research that ...
July 23, 2009
(Distributed by Amylyx Pharmaceuticals on June 15, 2020) Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimerās disease and other neurodegenerative diseases, today announced it has completed enrollment in the Phase II PEGASUS trial assessing AMX0035 in individuals with Alzheimerās disease. Amylyx completed ...
October 23, 2020
2019 Neuritic plaques surround amyloid deposits and are made up of swollen, dystrophic neural processes that contain aggregated phosphorylated tau. Neurofibrillary tangles are made up of phosphorylated tau that has abnormally been aggregated in Alzheimerās disease. Tau normally is microtubule adaptor protein involved in the highways of neurons that allow for ...
January 11, 2016
Elizabeth Louise (Brodeur) Thompson, 86, of East Falmouth, passed away at sunrise on Friday, June 16, 2023, surrounded by the love of her husband and children, beneath one of her beautiful handmade quilts. She is survived by her husband, best friend and dance partner extraordinaire, Edward, and will be immeasurably missed ...
June 19, 2023
Contact us about supporting Cure Alzheimer’s Fund at: Email: [email protected] Cure Alzheimerās Fund is a ādoing business asā name for the Alzheimerās Disease Research Foundation, a 501(c)(3) public charity with federal tax ID #52-239-6428. Please note that your information will be used only by Cure Alzheimer’s Fund to record and acknowledge this ...
September 24, 2017
In December, Cure Alzheimerās kicked off one of the most ambitious projects it has fundedāthe Collaboration to Infer Regulatory Circuits and to Uncover Innovative Therapeutic Strategies, or CIRCUITS. Following in the footsteps of the 3-D Drug Screen Consortium (3DDS), CIRCUITS tasks nine renowned researchers and their labs from six world-class ...
April 24, 2017
From our 2011 Annual Report. Ā Dear Friends, On behalf of the Board of Directors and the Research Consortium, we want to thank all the donors, researchers and academic institutional partners supporting Cure Alzheimerās Fund research for your help in making 2011 such a successful science year. Guided by leading scientists in the ...
December 5, 2012
